NCT03137940View on ClinicalTrials.gov

A Study on Safety of tDCS One-shot in UCP

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

March 20, 2017

Primary Completion Date

October 20, 2017

Study Completion Date

December 30, 2017

Conditions
Hemiplegic Cerebral Palsy
Interventions
DEVICE

real tDCS

one-shot of real tDCS session (1.5mA; 0.06 mA/cm2 for 20 minutes) with BrainStim Stimulator.

DEVICE

sham tDCS

one-shot of sham tDCS session (20 minutes) with BrainStim Stimulator.

Trial Locations (1)

Unknown

IRCCS Fondazione Stella Maris, Calambrone

All Listed Sponsors
lead

IRCCS Fondazione Stella Maris

OTHER

NCT03137940 - A Study on Safety of tDCS One-shot in UCP | Biotech Hunter | Biotech Hunter